Home / Resource Library / Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell LymphomaPirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma Results of a study examining pirtobrutinib for treatment of relapsed mantle cell lymphoma. (Abstract only)